Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8796455 Fused bicyclic mTOR inhibitors

Patent 8796455 was granted and assigned to OSI Pharmaceuticals on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

OSI Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87964550

Patent Inventor Names

Xin Chen0

Meizhong Jin0

Paula A. R. Tavares0

Qinghua Weng0

Andrew Philip Crew0

Apoorba Bharadwaj0

Ayako Honda0

Bijoy Panicker0

...

Date of Patent

August 5, 2014

Patent Application Number

137679470

Date Filed

February 15, 2013

Patent Citations Received

‌

US Patent 11661423 Heterocyclic compounds as RET kinase inhibitors

‌

US Patent 11680068 Compounds useful as RET inhibitors

Patent Primary Examiner

‌

Venkataraman Balasubramanian

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8796455 Fused bicyclic mTOR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API